Abstract
HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture of R5-tropic and X4-tropic HIV (dual/mixed, DM HIV). The level of infectivity for R5 virus (R5-RLU) varies among HIVinfected infants. HIV tropism and R5-RLU were measured in samples from HIV-infected Ugandan infants using a commercial assay. DM HIV was detected in 7/72 (9.7%) infants at the time of HIV diagnosis (birth or 6-8 weeks of age, 4/15 (26.7%) with subtype D, 3/57 (5.3 %) with other subtypes, P=0.013). A transition from R5-tropic to DM HIV was observed in only two (6.7%) of 30 infants over 6-12 months. Six (85.7%) of seven infants with DM HIV died, compared to 21/67 (31.3%) infants with R5-tropic HIV (p=0.09). Higher R5-RLU at 6-8 weeks was not associated with decreased survival. Infants with in utero infection had a higher median R5-RLU than infants who were HIV-uninfected at birth (p=0.025).
Keywords: CCR5, CXCR4, HIV-1, infant, survival, transmission, tropism, HIV, Ugandan Infants, HIV-infected infants, CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, R5-tropic, X4-tropic HIV, R5 virus, R5-RLU, CD4, T cell-tropic virus, chronic HIV infection, dual-tropic HIV, AIDS, single dose nevirapine, sdNVP, pMTCT), HIVNET, HIV Tropism, retroviral vector, HEK 293 cells, pseudoviruses, U87 cells, HIV pol subtype, Wilcoxon rank test, Fisher's exact test), human immunodeficiency virus type 1-infected mothers, V3 regions, HIV-1 subtypes
Current HIV Research
Title: Analysis of HIV Tropism in Ugandan Infants
Volume: 8 Issue: 7
Author(s): Clemensia Nakabiito, Susan H. Eshleman, Mary Glenn Fowler, Michelle McConnell, Flavia Matovu, Paul M. Bakaki, Allan Taylor, Laura A. Guay, Chineta Eure, Jessica D. Church, Deborah Donnell, Saad B. Omer, Danstan Bagenda, J. Brooks Jackson, Philippa Musoke, Anthony Mwatha and Wei Huang
Affiliation:
Keywords: CCR5, CXCR4, HIV-1, infant, survival, transmission, tropism, HIV, Ugandan Infants, HIV-infected infants, CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, R5-tropic, X4-tropic HIV, R5 virus, R5-RLU, CD4, T cell-tropic virus, chronic HIV infection, dual-tropic HIV, AIDS, single dose nevirapine, sdNVP, pMTCT), HIVNET, HIV Tropism, retroviral vector, HEK 293 cells, pseudoviruses, U87 cells, HIV pol subtype, Wilcoxon rank test, Fisher's exact test), human immunodeficiency virus type 1-infected mothers, V3 regions, HIV-1 subtypes
Abstract: HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture of R5-tropic and X4-tropic HIV (dual/mixed, DM HIV). The level of infectivity for R5 virus (R5-RLU) varies among HIVinfected infants. HIV tropism and R5-RLU were measured in samples from HIV-infected Ugandan infants using a commercial assay. DM HIV was detected in 7/72 (9.7%) infants at the time of HIV diagnosis (birth or 6-8 weeks of age, 4/15 (26.7%) with subtype D, 3/57 (5.3 %) with other subtypes, P=0.013). A transition from R5-tropic to DM HIV was observed in only two (6.7%) of 30 infants over 6-12 months. Six (85.7%) of seven infants with DM HIV died, compared to 21/67 (31.3%) infants with R5-tropic HIV (p=0.09). Higher R5-RLU at 6-8 weeks was not associated with decreased survival. Infants with in utero infection had a higher median R5-RLU than infants who were HIV-uninfected at birth (p=0.025).
Export Options
About this article
Cite this article as:
Nakabiito Clemensia, H. Eshleman Susan, Glenn Fowler Mary, McConnell Michelle, Matovu Flavia, M. Bakaki Paul, Taylor Allan, A. Guay Laura, Eure Chineta, D. Church Jessica, Donnell Deborah, B. Omer Saad, Bagenda Danstan, Brooks Jackson J., Musoke Philippa, Mwatha Anthony and Huang Wei, Analysis of HIV Tropism in Ugandan Infants, Current HIV Research 2010; 8 (7) . https://dx.doi.org/10.2174/157016210793499187
DOI https://dx.doi.org/10.2174/157016210793499187 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients
Current Drug Safety Vasotrophic Regulation of Age-Dependent Hypoxic Cerebrovascular Remodeling
Current Vascular Pharmacology The Role of Folate-supplementation in Depression: A Narrative Review
Current Psychopharmacology Identification of a Novel Intestinal First Pass Metabolic Pathway: NQO1 Mediated Quinone Reduction and Subsequent Glucuronidation
Current Drug Metabolism Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Current Drug Metabolism Pathological Brain Image Segmentation and Classification: A Survey
Current Medical Imaging Evolutioninthe Pharmacogenetics and Pharmacogenomics of Inflammatory Bowel Disease - Order Slowly Rises from the Chaos
Current Pharmacogenomics Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
Current Drug Targets Novel Therapeutic Strategies for the Homozygous Familial Hypercholesterolemia
Recent Patents on Cardiovascular Drug Discovery Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery Psychotherapy Through Video Game to Target Illness Related Problematic Behaviors of Children with Brain Tumor
Current Medical Imaging Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations
Current Medicinal Chemistry Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets High Throughput Determination of Gains and Losses of Genetic Material Using High Resolution BAC Arrays and Comparative Genomic Hybridization
Combinatorial Chemistry & High Throughput Screening Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry The Role of Culture and Ethnicity in the Adjustment to Gynecological Cancer
Current Women`s Health Reviews Fractal Analysis of Epithelial-Connective Tissue Interface in Basal Cell Carcinoma of the Skin
Current Bioinformatics Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics